Haemonetics issues $700M in 2.50% convertible notes due 2029; used to repurchase 2026 notes and repay revolver

HAEMONETICS CORP

Issued $700M (incl. $100M greenshoe) of 2.50% Convertible Senior Notes due June 1, 2029.
Used proceeds to repurchase $200M of 0% 2026 notes for $185.5M and repay $230M revolver balance.
Entered capped call transactions costing ~$88.2M with cap price $180.18 (100% premium over stock).
Initial conversion rate 8.5385 shares/$1,000 (~$117.12/share); notes redeemable from June 2027 if stock exceeds 130% of conversion price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.